6 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 11 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 6, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 6 | Completed 3, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Respiratory Sounds: new trials by email Literature Review of Respiratory Sounds trials Research Report on Respiratory Sounds
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genes, Soy Isoflavones, and Virus Soy Isoflavone Nutritional Supplements - Wheezing | Phase 1 / Phase 2 | Not yet recruiting | Ann & Robert H Lurie Children's Hospital of Chicago | 60 | 2026-10-01 | 2026-09-18 |
| Pharmacological Intervention for Symptomatic Snoring SAS2094AH and SAS2094BH, SAS2094AL and SAS2094BL, Placebo - Snoring | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 27 | 2018-12-17 | 2019-12-12 |
| A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma VR647 Inhalation Suspension (budesonide) 1 mg/2 mL delivered by the VR647 Inhalation System, 1 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer - Wheezing, Reactive Airway Disease | Phase 1 | Completed | Vectura Limited | 17 | 2017-12-18 | 2019-10-21 |
| Effect of Nasal Steroids in Snoring Intensity nasal spray Budesonide, Nasal spray Normal Saline - Snoring | Phase 1 | Completed | Ioannis Koutsourelakis | 24 | 2013-04-01 | 2013-09-16 |
| Study to Determine Results of Vibratory Stimulus on Subject's Neck Kai Strap - Sleep Apnea, Snoring | Phase 1 | Completed | Kai Medical, Inc. | 100 | 2011-11-01 | 2012-03-20 |
| Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics Epinephrine Inhalation Aerosol, HFA, Epinephrine Inhalation Aerosol - Asthma, Bronchospasm | Phase 1 / Phase 2 | Completed | Amphastar Pharmaceuticals, Inc. | 23 | 2010-08-01 | 2017-07-25 |
| Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients. E004 (epinephrine inhalation aerosol), 90 mcg/actuation, E004 Placebo, E004 (epinephrine inhalation aerosol), 125 mcg - Asthma | Phase 1 / Phase 2 | Terminated | Amphastar Pharmaceuticals, Inc. | 9 | 2009-12-01 | 2018-05-16 |
| Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood Cholecalciferol D3, Placebo tablet - Asthma | Phase 1 | Active not recruiting | Copenhagen Studies on Asthma in Childhood | 600 | 2009-03-01 | 2026-03-19 |
| Allergy Immunotherapy for the Reduction of Asthma Allergen extracts (subcutaneous injections), Standard of care - Wheezing, Asthma | Phase 1 / Phase 2 | Completed | Albert Einstein College of Medicine | 58 | 2008-10-01 | 2019-05-28 |
| Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS) Polidocanol Sclerotherapy - Apnea, Snoring | Phase 1 / Phase 2 | Unknown | Liaoyang Central Hospital | 30 | 2006-12-01 | 2006-11-22 |
| Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers. KEEPASLEEP enhanced breathing device - Snoring, Sleep Apnea Syndromes | Phase 1 | Unknown | Miller, Chipp St. Kevin, M.D. | 30 | 2004-06-01 | 2005-09-21 |
Snoring (5) · Asthma (4) · Apnea (2) · Dyspnea (2) · Hypersensitivity (2) · Sleep Apnea Syndromes (2) · Bronchial Spasm (1) · Eczema (1) · Infections (1) · Pulmonary Disease, Chronic Obstructive (1) · Sleep Apnea, Obstructive (1) · Status Asthmaticus (1)
Pathological Conditions, Signs and Symptoms (11) · Signs and Symptoms (11) · Signs and Symptoms, Respiratory (11) · Respiratory Tract Diseases (8) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Respiration Disorders (5) · Bronchial Diseases (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Respiratory Hypersensitivity (4) · Dyssomnias (3) · Nervous System Diseases (3) · Sleep Disorders, Intrinsic (3)
Budesonide (2) · Epinephrine (2) · Inhalation (1) · Injections, Subcutaneous (1) · Saline Solution (1) · Standard of Care (1)
Amphastar Pharmaceuticals, Inc. (2) · Albert Einstein College of Medicine (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Brigham and Women's Hospital (1) · Copenhagen Studies on Asthma in Childhood (1) · Ioannis Koutsourelakis (1) · Kai Medical, Inc. (1) · Liaoyang Central Hospital (1) · Miller, Chipp St. Kevin, M.D. (1) · Vectura Limited (1)
United States (8) · Denmark (1) · Greece (1)
Chipp K. Miller, M.D. (1) · Gabriele de Vos, M.D., M.Sc. (1) · Gary Burgess, MD (1) · Ioannis Koutsourelakis, MD (1) · Jim Shi, M.D., Ph.D. (1) · Rajesh Kumar, MD, MSCI (1) · Scott A Sands, PhD (1)
PMID 23176889, PMID 23706713, PMID 26813208, PMID 29077711, PMID 31381020, PMID 32091548, PMID 32150492, PMID 32423275, PMID 33289844, PMID 33418053, PMID 33653805, PMID 35105560, PMID 36184023, PMID 38072183, PMID 39077939, PMID 40471069, PMID 40865727, PMID 42149595
2008 (1)